India’s pharmaceutical and healthcare regulatory landscape continued to evolve significantly during the first half of 2026, with authorities introducing a range of new measures and frameworks. The changes were aimed at simplifying
More
The University of Michigan’s athletic department has faced a series of high-profile controversies over recent years, drawing intense public and legal scrutiny from multiple directions. Those controversies include the Connor Stallions sign-stealing
More
Linklaters has reported record financial results for the fiscal year ended April 30, 2026, marking the third consecutive year of double-digit profit growth for the Magic Circle firm. The London-headquartered law firm
More
While US markets dominate conversations about growth investing, the S&P 500 has only managed a roughly 10% gain so far in 2026. The tech-heavy index is packed with bloated megacaps carrying high
More
Global equity markets are facing renewed pressure as investors brace for a busy session of economic data and corporate developments on Tuesday. Futures markets pointed to a cautious open on Wall Street,
More
US equity markets moved higher as semiconductor stocks staged a broad recovery, lifting the major indices and restoring some confidence among investors. The technology sector led gains on the session, with chipmakers
More
Alcaraz’s wristwatch drew as much attention as the football itself during Sunday’s World Cup final between Spain and Argentina in what proved to be a memorable occasion. Spanish tennis world number one
More
Novartis chief executive Vas Narasimhan has expressed confidence in the long-term commercial prospects of the company’s injectable cholesterol-lowering treatment, Leqvio. His comments come in direct response to the recent regulatory approval of
More
Gilead Sciences and Merck have reported positive results from two phase 3 trials backing what could become the first long-acting oral HIV treatment taken once weekly. The combination regimen pairs Merck’s islatravir
More
Defence stocks rallied sharply in London on Tuesday after John Healey, the former defence secretary, was named as Britain’s new Chancellor of the Exchequer. Investors responded positively to the appointment, which was
More